Bayer AG agreed to pay Kumquat Biosciences Inc. as much as $1.3 billion to gain a potential new cancer medicine and boost its struggling pharma division’s growth prospects.
www.bloomberg.com
#Bayer #Pay #Billion #Kumquat #Cancer #Drug #Pharma #Push
Bayer to Pay $1.3 Billion for Kumquat Cancer Drug in Pharma Push
